AxoGen, Inc.AXGNNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+8.7%
5Y CAGR+13.0%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+8.7%/yr
vs +21.5%/yr prior
5Y CAGR
+13.0%/yr
Recent deceleration
Acceleration
-12.8pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.8x
Solid growth
Streak
9 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$32.88M+18.4%
2024$27.77M+1.6%
2023$27.34M+6.7%
2022$25.63M+6.0%
2021$24.18M+35.5%
2020$17.85M+1.9%
2019$17.51M+48.8%
2018$11.77M+75.7%
2017$6.70M+59.0%
2016$4.21M-